RT Conference Proceedings
T1 A randomized phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse: The PEACE 2 trial from Unicancer
A1 Blanchard, P.
A1 Foulon, S.
A1 Artignan, X.
A1 Carles, J.
A1 Ronchin, P.
A1 Gizzi, M.
A1 Villa Freixa, S.
A1 Valdagni, R.
A1 Sargos, P.
A1 Marques Da Costa, L. A.
A1 Duberge, T.
A1 Guillot, A.
A1 Latorzeff, I.
A1 Gallardo, E.
A1 Saez, M. I.
A1 Abadie-Lacourtoisie, S.
A1 Bennamoun, M.
A1 Hasbini, A.
A1 Tantot, F.
A1 Fizazi, K.
PB Elsevier
SN 0923-7534
YR 2021
FD 2021-09-21
LK https://hdl.handle.net/10668/27061
UL https://hdl.handle.net/10668/27061
LA en
DS RISalud
RD Apr 17, 2025